Login / Signup
Heike Dahmen
ORCID
Publication Activity (10 Years)
Years Active: 2022-2023
Publications (10 Years): 2
Top Topics
Early Stage
Hiv Infected
Tyrosine Kinase
Squamous Cell
Top Venues
Molecular cancer therapeutics
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Audrey Turchick
,
Astrid Zimmermann
,
Li-Ya Chiu
,
Heike Dahmen
,
Brian Elenbaas
,
Frank T Zenke
,
Andree Blaukat
,
Lyubomir T Vassilev
Selective inhibition of ATM-dependent double-strand break repair and checkpoint control synergistically enhances the efficacy of ATR inhibitors.
Molecular cancer therapeutics
(2023)
Astrid Zimmermann
,
Frank T Zenke
,
Li-Ya Chiu
,
Heike Dahmen
,
Ulrich Pehl
,
Thomas Fuchss
,
Thomas Grombacher
,
Beatrix Blume
,
Lyubomir T Vassilev
,
Andree Blaukat
A New Class of Selective ATM Inhibitors as Combination Partners of DNA Double-Strand Break Inducing Cancer Therapies.
Molecular cancer therapeutics
21 (6) (2022)